CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Medivation

For profitContributed to NME

Also known as: Medivation, Inc. | Medviation | Medviation, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Sep 1, 2005

First marketed drug

Feb 1, 2007

First NDA

Aug 31, 2012

Last known activity

Aug 21, 2017

Acquired by Pfizer on Sep 28, 2016

Timeline

2000s

  1. Jul 1, 2003

    Medivation— Founded

2010s

  1. Aug 31, 2012

    enzalutamide— NDA Organization

  2. Sep 28, 2016

    Pfizer— Acquired By

Drugs by trial phase (37 distinct, 99 trials)

Phase 3 (4 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

Recent trials (50)

Details

Founded
San Francisco, CA, US Jul 1, 2003
First NDA
Aug 31, 2012
Last known activity
Aug 21, 2017

Designations held

  • Fast track
  • Priority review

Notes

Acquired by Pfizer